© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
September 22, 2021
Doctors and pharmacists discuss OTC and prescription treatment options and use during webcast.
September 20, 2021
An anti-vascular endothelial growth factor therapy, ranibizumab prevents vision loss in patients with retinal vascular disorders, which can cause irreversible blindness or visual impairments in adults.
September 10, 2021
The research team analyzed the associations between maternal diabetes before or during pregnancy and the risk of high refractive error (RE), which are conditions in which there is a failure of the eye to properly focus images on the retina.
August 19, 2021
According to the investigators, both trials demonstrated an overall well-tolerated safety profile for brolucizumab.
August 17, 2021
A panel of experts comment on new therapeutic agents being developed and discuss their final thoughts on dry eye disease.
August 12, 2021
Lisa M. Nijm, MD, JD, educates on Eysuvis, an FDA-approved prescription therapeutic for dry eye disease.
August 10, 2021
The panel discusses the possible prescription treatments for dry eye disease.
August 06, 2021
A panel of pharmacists and doctors explain when a patient should seek professional help for dry eye disease.
August 05, 2021
Top-line data from the NORSE TWO trial demonstrated that the treatment met the primary and key secondary endpoint for efficacy with clinically impactful change observed for treated patients.
Monazzah Akbar Sarwar, PharmD, continues the conversation for over-the-counter treatment options for patients with dry eye disease.